South Korea to select 50 K-Pharma Bio Frontier companies annually
AI Summary- South Korea will select and support 50 pharmaceutical and biotech ventures annually.
- The program covers candidate discovery, trials, commercialization, investment and overseas expansion.
- The ministries discussed the plan with eight venture chief executives at Lunit on the 17th.